Ophthalmic Viscosurgical Devices Market to hit $790mn by 2024: Global Market Insights Inc. Ophthalmic Viscosurgical Devices Market size is set to exceed USD 790 million by 2024; according to a new research report by Global Market Insights, Inc. Shifting demographic trends towards increased geriatric population is a pivotal factor driving the global ophthalmic viscosurgical devices market size. Demand is primarily generated by growing elderly population associated with high potential for ophthalmic surgeries. Longer life expectancy and growing shift towards an older average age has led to increased incidences of cataract driving the global ophthalmic viscosurgical devices market. OVDs are an integral part of the modern anterior segment surgery. The introduction of different multifocal IOL options that can fill gaps throughout the complete range of vision has strongly improved patient satisfaction and the quality of distance vision.
Most common eye diseases affecting the older age group include advanced agelinked macular degeneration, diabetic retinopathy, cataracts, glaucoma, and blindness or poor vision. Many older people develop macular degeneration as part of the body's natural aging process. Cataract surgery was the highest revenue generating application in 2015 due to high global prevalence. Increasing number of vitreoretinal surgeries among geriatric people will drive procedure demand. Development of a low-cost vitreoretinal surgical system designed for emerging regions will expand vitreoretinal surgery demand. Dispersive OVDs market offers advantages of using the viscoelastic soft-shell technique for routine cases, especially for complex procedures, which could result in more than 12% CAGR by 2024. Cohesive ophthalmic viscosurgical devices market will seize close to 40% share by 2024, due to their tendency to stick together and move as a mass, which plays an important role in OVD retention in the anterior chamber during phacoemulsification. Some of the available viscous cohesive OVDs are Provisc, Healon, Amvisc and Amvisc Plus. Europe ophthalmic viscosurgical devices market, especially across Germany, UK and France will experience notable growth; the region accounted for more than 30% of the 2015 global revenue. Demographic shift is set to lead to an increase in the overall sales of Intraocular Lens (IOLs). Age-related macular degeneration (AMD), glaucoma and diabetic retinopathy are the most common cause of blindness in Europe. 1|Page